Rocket Pharmaceuticals Receives FDA RMAT Designation for Leukocyte Adhesion Deficiency-I
Rocket Pharmaceuticals Receives FDA RMAT Designation for Leukocyte Adhesion Deficiency-I...
Read MoreRocket Pharmaceuticals Receives FDA RMAT Designation for Leukocyte Adhesion Deficiency-I...
Read MoreAddress Avenida Escazu, Building 202, Suite 401Escazu, San Jose, Costa Rica Phone 1.800.601.8290...
Read MoreA Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell...
Read MoreMesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients In a phase 2...
Read MoreFDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem...
Read More